268 related articles for article (PubMed ID: 34208064)
1. Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
Yamanaka G; Ishida Y; Kanou K; Suzuki S; Watanabe Y; Takamatsu T; Morichi S; Go S; Oana S; Yamazaki T; Kawashima H
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208064
[TBL] [Abstract][Full Text] [Related]
2. Anakinra and tocilizumab in the chronic phase of febrile infection-related epilepsy syndrome (FIRES): Effectiveness and safety from a case-series.
Aledo-Serrano A; Hariramani R; Gonzalez-Martinez A; Álvarez-Troncoso J; Toledano R; Bayat A; Garcia-Morales I; Becerra JL; Villegas-Martínez I; Beltran-Corbellini A; Gil-Nagel A
Seizure; 2022 Aug; 100():51-55. PubMed ID: 35759951
[TBL] [Abstract][Full Text] [Related]
3. Successful Treatment of Pediatric FIRES With Anakinra.
Yang JH; Nataraj S; Sattar S
Pediatr Neurol; 2021 Jan; 114():60-61. PubMed ID: 33227629
[No Abstract] [Full Text] [Related]
4. Second-line immunotherapy in new onset refractory status epilepticus.
Hanin A; Muscal E; Hirsch LJ
Epilepsia; 2024 May; 65(5):1203-1223. PubMed ID: 38430119
[TBL] [Abstract][Full Text] [Related]
5. Febrile infection-related epilepsy syndrome treated with anakinra.
Kenney-Jung DL; Vezzani A; Kahoud RJ; LaFrance-Corey RG; Ho ML; Muskardin TW; Wirrell EC; Howe CL; Payne ET
Ann Neurol; 2016 Dec; 80(6):939-945. PubMed ID: 27770579
[TBL] [Abstract][Full Text] [Related]
6. Functional deficiency in endogenous interleukin-1 receptor antagonist in patients with febrile infection-related epilepsy syndrome.
Clarkson BDS; LaFrance-Corey RG; Kahoud RJ; Farias-Moeller R; Payne ET; Howe CL
Ann Neurol; 2019 Apr; 85(4):526-537. PubMed ID: 30779222
[TBL] [Abstract][Full Text] [Related]
7. Systemic autoinflammation with intractable epilepsy managed with interleukin-1 blockade.
DeSena AD; Do T; Schulert GS
J Neuroinflammation; 2018 Feb; 15(1):38. PubMed ID: 29426321
[TBL] [Abstract][Full Text] [Related]
8. Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.
Koh S; Wirrell E; Vezzani A; Nabbout R; Muscal E; Kaliakatsos M; Wickström R; Riviello JJ; Brunklaus A; Payne E; Valentin A; Wells E; Carpenter JL; Lee K; Lai YC; Eschbach K; Press CA; Gorman M; Stredny CM; Roche W; Mangum T
Epilepsia Open; 2021 Mar; 6(1):62-72. PubMed ID: 33681649
[TBL] [Abstract][Full Text] [Related]
9. Rasmussen's syndrome treated with anakinra.
Arcan A; Kızılkılıç EK; Gündüz A; Unkun R; Vezzani A; Özkara Ç
J Neurol; 2024 Feb; 271(2):723-726. PubMed ID: 37922068
[TBL] [Abstract][Full Text] [Related]
10. Febrile Infection-Related Epilepsy Syndrome Treated Successfully With Anakinra in a 21-Year-Old Woman.
Westbrook C; Subramaniam T; Seagren RM; Tarula E; Co D; Furstenberg-Knauff M; Wallace A; Hsu D; Payne E
WMJ; 2019 Oct; 118(3):135-139. PubMed ID: 31682750
[TBL] [Abstract][Full Text] [Related]
11. Centromedian thalamic nuclei deep brain stimulation and Anakinra treatment for FIRES - Two different outcomes.
Sa M; Singh R; Pujar S; D'Arco F; Desai N; Eltze C; Hughes E; Al Obaidi M; Eleftheriou D; Tisdall M; Selway R; Cross JH; Kaliakatsos M; Valentin A
Eur J Paediatr Neurol; 2019 Sep; 23(5):749-754. PubMed ID: 31446001
[TBL] [Abstract][Full Text] [Related]
12. Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
Lai YC; Muscal E; Wells E; Shukla N; Eschbach K; Hyeong Lee K; Kaliakatsos M; Desai N; Wickström R; Viri M; Freri E; Granata T; Nangia S; Dilena R; Brunklaus A; Wainwright MS; Gorman MP; Stredny CM; Asiri A; Hundallah K; Doja A; Payne E; Wirrell E; Koh S; Carpenter JL; Riviello J
Ann Clin Transl Neurol; 2020 Dec; 7(12):2467-2474. PubMed ID: 33506622
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of Anakinra in the relapsing chronic phase of febrile infection-related epilepsy syndrome.
Dilena R; Mauri E; Aronica E; Bernasconi P; Bana C; Cappelletti C; Carrabba G; Ferrero S; Giorda R; Guez S; Scalia Catenacci S; Triulzi F; Barbieri S; Calderini E; Vezzani A
Epilepsia Open; 2019 Jun; 4(2):344-350. PubMed ID: 31168503
[TBL] [Abstract][Full Text] [Related]
14. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
[TBL] [Abstract][Full Text] [Related]
15. An
Cerovic M; Di Nunzio M; Craparotta I; Vezzani A
Front Neurol; 2023; 14():1129138. PubMed ID: 37034097
[TBL] [Abstract][Full Text] [Related]
16. The future of the IL-1 receptor antagonist anakinra: from rheumatoid arthritis to adult-onset Still's disease and systemic-onset juvenile idiopathic arthritis.
Kalliolias GD; Liossis SN
Expert Opin Investig Drugs; 2008 Mar; 17(3):349-59. PubMed ID: 18321234
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 Blockade With Tocilizumab in Anakinra-Refractory Febrile Infection-Related Epilepsy Syndrome (FIRES).
Stredny CM; Case S; Sansevere AJ; Son M; Henderson L; Gorman MP
Child Neurol Open; 2020; 7():2329048X20979253. PubMed ID: 33403221
[TBL] [Abstract][Full Text] [Related]
18. The Beneficial Outcome of Subsequent Treatment with Anakinra during the Chronic Phase of Febrile Infection-Related Epilepsy Syndrome (FIRES): A Case Report.
Cupane TL; Strautmanis J; Setlere S; Diriks M; Auzenbaha M
Neurol Int; 2023 Dec; 15(4):1489-1496. PubMed ID: 38132976
[TBL] [Abstract][Full Text] [Related]
19. PASylation of IL-1 receptor antagonist (IL-1Ra) retains IL-1 blockade and extends its duration in mouse urate crystal-induced peritonitis.
Powers NE; Swartzwelter B; Marchetti C; de Graaf DM; Lerchner A; Schlapschy M; Datar R; Binder U; Edwards CK; Skerra A; Dinarello CA
J Biol Chem; 2020 Jan; 295(3):868-882. PubMed ID: 31819009
[TBL] [Abstract][Full Text] [Related]
20. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage.
Librizzi L; Noè F; Vezzani A; de Curtis M; Ravizza T
Ann Neurol; 2012 Jul; 72(1):82-90. PubMed ID: 22829270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
